# Purdue Pharma L.P., Stamford, CT – FDA Inspections

Source: https://www.keypedia.com/companies/purdue-pharma-lp/12a191f7-7216-4b7c-aa90-a6e20688a346

> Inspection records and compliance data for Purdue Pharma L.P. in Stamford, Connecticut. 8 FDA inspections on record, 3 Form 483s, last inspected October 05, 2023.

---

## Details

- Name: Purdue Pharma L.P.
- FEI Number: 3004365793
- Address Line 1: 201 Tresser Blvd
- City: Stamford
- State: Connecticut
- Zip Code: 06901
- Country Name: United States
- Address: 201 Tresser Blvd, Stamford, Connecticut 06901, United States
- Country: United States

## Related Documents

- [483 - Purdue Pharma L.P. - 2023-10-05](https://www.keypedia.com/records/483/purdue-pharma-lp/13b4c7ad-e4c7-4f1a-af57-992d0ae1df99) — source: FDA, date: October 5, 2023
- [FDA Inspection 1219674 - Purdue Pharma L.P. - 2023-10-05](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/817234d2-cd59-4948-a2ce-9a2fd906ed9e) — classification: Voluntary Action Indicated (VAI), source: FDA, date: October 5, 2023
- [483 - Purdue Pharma L.P. - 2019-03-29](https://www.keypedia.com/records/483/purdue-pharma-lp/6c6ff294-369e-4833-9071-4b0656b73654) — source: FDA, date: March 29, 2019
- FDA Inspection 1084657 - Purdue Pharma L.P. - 2019-03-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [FDA Inspection 1084657 - Purdue Pharma L.P. - 2019-03-29](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/5c8a08a9-c10a-4fc6-875d-a0744f103817) — classification: Voluntary Action Indicated (VAI), source: FDA, date: March 29, 2019
- [FDA Inspection 994812 - Purdue Pharma L.P. - 2016-12-06](https://www.keypedia.com/records/fda_inspections/purdue-pharma-lp/cdb4e580-db3e-4dc1-8537-5416abe48590) — source: FDA, date: December 6, 2016
- FDA Inspection 994812 - Purdue Pharma L.P. - 2016-12-06 — source: FDA, date: December 6, 2016
- FDA Inspection 979977 - Purdue Pharma L.P. - 2016-07-28 — classification: No Action Indicated (NAI), source: FDA, date: July 28, 2016
- FDA Inspection 979095 - Purdue Pharma L.P. - 2016-07-06 — classification: No Action Indicated (NAI), source: FDA, date: July 6, 2016
- FDA Inspection 783424 - Purdue Pharma L.P. - 2012-05-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 25, 2012
- FDA Inspection 783424 - Purdue Pharma L.P. - 2012-05-25 — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2012
- FDA Inspection 783424 - Purdue Pharma L.P. - 2012-05-25 — classification: No Action Indicated (NAI), source: FDA, date: May 25, 2012

## Related Companies

- [Neos Therapeutics, LP](https://www.keypedia.com/companies/neos-therapeutics-lp/b0c09540-d002-4817-8f57-7903d10d044f)
- [FAR Specialty Products, Inc.](https://www.keypedia.com/companies/far-specialty-products-inc/4c72d071-0e94-4e7b-b968-b1aca96ea5e0)
- [Thibiant International, Inc.](https://www.keypedia.com/companies/thibiant-international-inc/5df84acc-2ce1-4b93-9b6b-f7e8379490fe)
- [Sage Pharmaceuticals, Inc.](https://www.keypedia.com/companies/sage-pharmaceuticals-inc/84cd8c46-e46f-497b-bcea-1e20b11f2dbd)
- [Bullet Line LLC](https://www.keypedia.com/companies/bullet-line-llc/e6c5661b-9690-4a10-a29e-c2376a4cc0ca)
- [PLZ Corp](https://www.keypedia.com/companies/plz-corp/c12286c0-ab29-4ea7-82c7-e402764afab2)
- [Keystone Laboratories, Inc.](https://www.keypedia.com/companies/keystone-laboratories-inc/5e1c645f-1f15-4149-8ce3-f73d0b0eb564)
- [Ridge Properties, LLC](https://www.keypedia.com/companies/ridge-properties-llc/fab335ea-7578-4709-ac3b-65cb4a3f9777)
- [Nutrition & Biosciences USA 1 LLC](https://www.keypedia.com/companies/nutrition-biosciences-usa-1-llc/94a475b3-8af2-4dfc-b0b4-d6cf29091a6d)
- [L'OREAL USA, INC.](https://www.keypedia.com/companies/loreal-usa-inc/7d3b71d5-dca8-478c-ac59-221294019eda)

## Related Officers

- [issuing_officer](https://www.keypedia.com/people/kent-a-conforti/8d3d3e82-cd97-420e-8840-df92d6eeba09)
- [investigator](https://www.keypedia.com/people/tyanna-n-hadley/8fdebfd7-d6f3-44ab-9dcb-864ab6d55d53)
